WELLS FARGO & COMPANY/MN

Position in DBVT — DBV Technologies S.A.

CIK 72971 SAN FRANCISCO, CA

Position in DBVT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,920

-$1,347 QoQ

Shares Held

300

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#62

of 78 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. DBVT ranks #336 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,920	300	0.0%	Shares	Defined	2026-08-14
2026-03-31	$6,267	300	0.0%	Shares	Defined	2026-05-11
2025-12-31	$5,751	300	-83.9%	Shares	Defined	2026-02-13
2022-09-30	$3,293	1,861	0.0%	Shares	Defined	2022-11-14
2022-06-30	$4,745	1,861	0.0%	Shares	Defined	2022-08-12
2022-03-31	$2,958	1,861	0.0%	Shares	Defined	2022-05-16
2021-12-31	$2,977	1,861	0.0%	Shares	Defined	2022-02-14
2021-09-30	$9,118	1,861	-59.5%	Shares	Defined	2021-11-15
2021-06-30	$25,105	4,598	+39.0%	Shares	Defined	2021-08-16
2021-03-31	$17,631	3,308	+6.1%	Shares	Defined	2021-05-13
2020-12-31	$8,169	3,118	—	Shares	Defined	2021-02-09
No filing history on record for this holder in this stock.